Pune, India, December 2021, MRFR Press Release/- Market Research Future has published a Cooked Research Report on the Global Saliva Collection and Diagnostic Market.

Saliva Collection & Diagnostics Market Report Highlights

Global Saliva Collection and Diagnostic Market is expected to have a market value of USD 6.56 billion by 2032 at 11.34% CAGR during forecast 2023-2032.

Saliva is a translational research tool and diagnostic medium which is being utilized as a part of novel approaches to give molecular biomarkers a variety of oral and systemic infections and conditions. The capacity to break down saliva to screen health conditions and diseases is an exceedingly alluring objective for oral health advancement and research. Saliva tests have been used to detect cancer risk, periodontitis, breast cancer, oral cancer, salivary gland diseases, and systemic disorders such as hepatitis and HIV. Cost-effective saliva collection and diagnostic method globally is driving the growth of this segment.

Segment Analysis

Global Saliva Collection and Diagnostic Market based on the site of collection has been segmented into parotid gland collections, submandibular/sublingual gland collection, minor salivary glands collection. Based on application, the market has been segmented into disease diagnosis forensics and pharmaceutical and biotechnology companies. The market for the global saliva collection and diagnostic market, by end-user, is bifurcated into hospitals/dental clinics and diagnostic centers and investigation laboratories.

Regional Analysis

Global Saliva Collection and Diagnostic Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas has been segmented into North America and Latin America, with North America further divided into the US and Canada. The Americas led the market and accounted for the largest share in 2019 due to well-established healthcare system, rising number of patient’s systemic diseases, and technological innovation in saliva collection and diagnostic.

The European saliva collection and diagnostic market has been further segmented into Western Europe and Eastern Europe. The Western Europe saliva collection and diagnostic market has further been classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The increasing incidence of chronic diseases such as cancer in European countries and rising research and development activity as well as new product launch and approval are expected to propel the demand for saliva collection and diagnostic devices during the forecast period.

The saliva collection and diagnostic market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific markets. The Asia-Pacific market is expected to register the highest growth rate over the forecast period from 2020 to 2027. In addition, the rising geriatric population leading to a risk of chronic disease and technological advancements in saliva collection diagnostic devices in the Asia-Pacific countries are also attributing to the market growth during the forecast period.

The Middle East & Africa saliva collection and diagnostic market is segmented into the Middle East and Africa. The rise in subsidiaries and distributorship in the region contributes heavily to the growth of this market. For instance, DNA Genotek Inc., a subsidiary of OraSure Technologies, Inc., operates in Israel, Saudi Arabia, and Saudi Arabia through Pronto, Integrated Gulf Biosystems (IGB), and Whitehead Scientific (Pty) Ltd, respectively.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Saliva Collection & Diagnostics Market Research Report

Key Players

MRFR recognizes the following companies as the Key Players in the Global Saliva Collection and Diagnostic Market— Neogen Corporation. (US)., SARSTEDT AG & Co. KG (Germany), Quest Diagnostics (US), OraSure Technologies (US), and Abbott Laboratories (US).

Key Findings of the Study

• The Global Saliva Collection and Diagnostic Market is estimated to reach USD 6.56 billion by 2032 at a CAGR of 11.34% during the assessment period of 2023 to 2032.


• The Americas accounted for the largest share of the global saliva collection and diagnostic market due to the presence of prominent players in the US, high uptake rate, and product clearances from regulatory authorities.


• Based on site of collection, the parotid gland collection segment accounted for the largest market share of 8.71% in 2019.


• On the basis of application, the forensics segment was the fastest-growing segment during the forecast period with a CAGR of 10.72%.


• Based on end-user, the hospitals & dental clinics segment dominated the market with a CAGR of 10.37%.